Swift sonic thrombolysisreduces risk of bleeding
A new endovascular sonic lysis system reduces the risk of hemorrhage by dissolving clots faster than conventional catheter thrombolysis or mechanically assisted thrombectomy devices.
A new endovascular sonic lysis system reduces the risk of hemorrhage by dissolving clots faster than conventional catheter thrombolysis or mechanically assisted thrombectomy devices.
Dr. Constantino Peña, an interventional radiologist at the Baptist Cardiac & Vascular Institute in Miami, showed how the procedure works during a live televised case demonstration at the 2009 International Symposium on Endovascular Therapy. A 74- year-old patient with a blocked leg artery underwent ultrasound-enhanced thrombolysis with a tenecteplase/heparin infusion.The procedure required only half the usual thrombolytic dose and ended with a dissolved clot 12 hours later. Other techniques need at least 24 hours to be effective, which heightens bleeding risks associated with thrombolytics. BCVI specialists have performed the procedure on more than 100 patients using this technique, Peña said.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
